Avioli L V, Birge S, Lee S W, Slatopolsky E
J Clin Invest. 1968 Oct;47(10):2239-52. doi: 10.1172/JCI105909.
The absorption and metabolism of vitamin D(3)-(3)H was studied in eight patients with chronic renal failure. Although the intestinal absorption of vitamin D(3)-(3)H was normal, the metabolic fate of the vitamin was abnormal as characterized by a twofold increase in fractional turnover rate, an abnormal accumulation of biologically inactive lipid-soluble metabolites, and the urinary excretion of both vitamin D(3)-(3)H and biologically inactive metabolites. Neither alterations in water-soluble vitamin D(3) metabolites nor qualitative abnormalities in protein-binding of vitamin D(3) were observed in the uremic subjects. Although hemodialysis proved ineffectual in reversing the observed abnormalities in vitamin D(3) metabolism and excretion, renal homotransplantation was completely successful in this regard. These experiments support the conclusion that the resistance to therapeutic doses of vitamin D often seen in patients with chronic renal failure and renal osteodystrophy results from an acquired defect in the metabolism and excretion of vitamin D.
对8例慢性肾衰竭患者进行了维生素D(3)-(3)H的吸收与代谢研究。尽管维生素D(3)-(3)H的肠道吸收正常,但该维生素的代谢命运异常,其特征为分数周转率增加两倍、生物活性无的脂溶性代谢产物异常蓄积以及维生素D(3)-(3)H和生物活性无的代谢产物经尿液排泄。在尿毒症患者中未观察到水溶性维生素D(3)代谢产物的改变,也未观察到维生素D(3)蛋白结合的定性异常。尽管血液透析证明无法逆转所观察到的维生素D(3)代谢和排泄异常,但肾同种移植在这方面完全成功。这些实验支持以下结论:慢性肾衰竭和肾性骨营养不良患者中常见的对治疗剂量维生素D的抵抗是由维生素D代谢和排泄的后天缺陷所致。